Literature DB >> 8048962

Presence of cholesterol 7 alpha-hydroxylase enzyme protein in COS-cells leads to increased HMG CoA reductase activity.

E Sudjana-Sugiaman1, G Eggertsen, P Sjöblom, Y Maeda, M Rudling, K Okuda, I Björkhem.   

Abstract

Transfection of COS-cells with a cDNA coding for human cholesterol 7 alpha-hydroxylase resulted in significant production of cholesterol 7 alpha-hydroxylase enzyme and intracellular accumulation of the product, 7 alpha-hydroxycholesterol. Presence of this enzyme activity was always associated with increased HMG CoA reductase activity. In five different independent transfection experiments resulting in a cholesterol 7 alpha-hydroxylase activity of 0.26 +/- 0.05 pmol/min/mg in the transfected cells, the HMG CoA reductase activity increased to 158 +/- 14% of that of the control cells (p < 0.01). This change was not associated with significant changes in the cholesterol content or LDL-receptor expression of the COS-cells. It is evident that the two key enzymes in cholesterol synthesis and degradation interact with each other also in extra-hepatic cells that are unable to degrade cholesterol into bile acids. Possible mechanisms for the finding is discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8048962     DOI: 10.1006/bbrc.1994.2014

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  On the formation of 7-ketocholesterol from 7-dehydrocholesterol in patients with CTX and SLO.

Authors:  Ingemar Björkhem; Ulf Diczfalusy; Anita Lövgren-Sandblom; Lena Starck; Monica Jonsson; Keri Tallman; Henrik Schirmer; Lilian Bomme Ousager; Peter J Crick; Yuqin Wang; William J Griffiths; F Peter Guengerich
Journal:  J Lipid Res       Date:  2014-04-25       Impact factor: 5.922

2.  Adenovirus-mediated transfer of a gene encoding cholesterol 7 alpha-hydroxylase into hamsters increases hepatic enzyme activity and reduces plasma total and low density lipoprotein cholesterol.

Authors:  D K Spady; J A Cuthbert; M N Willard; R S Meidell
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.